Global Cartilage Repair Market By Treatment Modality (Cell-Based and Non-Cell-Based), By Application (Hyaline and Fibro-cartilage), By Treatment Type (Palliative and Intrinsic Repair Stimulus), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032
- account_circleAbout Me
Cartilage Repair Market Overview
The global cartilage repair market was valued at US$ 5,573 million in 2021 and is projected to grow at a 5.6% CAGR during the forecast period. Global market growth is expected to be driven by the increasing prevalence of joint and bone disorders like Osteoarthritis (OA), or arthritis. Technological advancements in cartilage restoration are also key drivers.
Global Cartilage Repair Market Analysis
Treatment Mode Analysis
Cell-based and non-cell-based treatment methods were the main focus of this study. In 2021, the cell-based segment was the dominant market and is expected to continue its dominance over the forecast period. Market growth is expected to be supported by the growing preference for Chondrocyte Transplants for damaged articular cartilage.
The segment that is not cell-based can further be classified as tissue scaffolds and cells-free composites. Tissue scaffold can stimulate bone and cartilage growth when it is transplanted into joints like the knees.
Application Analysis
This application segment comprises fibro and hyaline. This industry is expected to be dominated by the hyaline sector during the forecast period due to the rising incidence of physical trauma throughout the globe. Patients may develop osteochondral, and chondral lesions. According to statistics from the Centers for Disease Control and Prevention, approximately 1,99,800 people are killed each year by fatal injuries in the United States.
According to the CDC, about 3.1 million people were hospitalized in 2021 and 30 million patients were treated in an ER for non-fatal injuries. Additionally, 34,248 people died from motor vehicle crashes in 2021. 354,323 children were also treated in U.S. emergency rooms for fall injuries. The market is expected to grow due to the increase in fatal and non-fatal injuries.
Because of the high susceptibility to injury to hyaline-related cartilage, the segment hyaline is expected to grow the fastest over the forecast period. Additionally, sports-related injuries are causing a surge in the number of articular cartilage deformities in the knee and other joints. This is expected to support segment growth.
Treatment Type Analysis
The treatment type can be divided into intrinsic repair stimulation and palliative. In 2021, the intrinsic repair stimuli segment held a significant share due to the extensive use of micro fracture during cartilage repair operations. The intra-intrinsic repair stimulus is microfracture and drilling techniques which stimulate Mesenchymal Stem Cells, to the cartilage site to form repair tissue.
Further classifications of the palliative segment include viscosupplementation, debridement & lace. Viscosupplement refers to injecting hyaluronic in a joint to replenish or supplement the synovial fluid. Market share for viscosupplementation will increase over the forecast period due to an increase in OA-induced discomfort and rising demand to regenerate hyaline cartilage.
Key Market Segments
By Treatment Modality
- Cell-Based
- Non-Cell-Based
By Application
- Hyaline
- Fibro-cartilage
By Treatment Type
- Palliative
- Intrinsic Repair Stimulus
Market Dynamics
The growing geriatric population and related factors like obesity are leading to an increase in OA. This condition is a major cause of disability in the U.S. It affected over 22 million Americans in 2021 and is projected to affect 43 million in the forecast period. In the U.S., 14 Million people experience knee pain. This is a major driver of this industry's growth.
Over the forecast period, the global rise in obesity and diabetes will drive growth in the cartilage market. Increased cartilage loss can be caused by diabetes. The forecast period will also see an increase in obese people in Latin America and the MEA regions. This is expected to drive demand for cartilage restoration products.
The American Heart Association (AHA), estimated that the global geriatric population would account for about 18% by 2032. This group is susceptible to developing chronic illnesses and is predicted to be a major driver of cartilage repair and market growth over the forecast period.
The forecast period will see a surge in road accidents worldwide and sports-related injuries that result in joint and bone injuries. This is expected to increase the demand for cartilage replacement products.
Every year, around 41 million children and teens participate in youth sports in America. This increases the number of athletes who sustain injuries, which drives demand for products to repair them. Research data from the American Orthopaedic Society for Sports Medicine shows that more than 3.5 million athletes receive medical treatment each year for injuries sustained in sports. Sports and recreational activities were responsible for approximately 23% and 55% respectively of all traumatic brain injuries among American children.
Regional Analysis
North America held a 49% market share of cartilage repair in 2021 due to an increasing number of musculoskeletal conditions, target population, and changing lifestyles in the U.S.A and Canada. Europe is expected to benefit from the increasing prevalence of osteoporosis, which has been reported in France, Germany, and the U.K. A report from the National Health Service (NHS) states that osteoporosis affects more than 3.0million people in the UK annually.
International Diabetes Federation (IDF), estimated that China had 115 Million cases of diabetes. In Japan, almost 8 million cases were reported, while 1 million cases were reported in Australia. Asia Pacific is expected to have a relatively higher CAGR during the forecast period than other regions.
The increasing incidence of osteoporosis, both in Australia and New Zealand has led to increased cartilage damage. This will encourage growth in this vertical. Osteoporosis, which affects more than 3 million Australians, is considered a common condition. Statistics from the Burden for Osteoporosis New Zealand show that osteoporosis was responsible for 84,000 fractures in 2007 at different locations in the skeleton.
Key Regions and Countries covered іn thе rероrt:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Russia
- Spain
- Rest of Europe
- APAC
- China
- Japan
- South Korea
- India
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- MEA
- GCC
- South Africa
- Israel
- Rest of MEA
Market Share & Key Players Analysis:
Conmed Corporation, Johnson & Johnson, RTI Surgical, Inc, Smith & Nephew Plc, Melsungen AG, and Osiris Therapeutics Inc., are just a few of the key players that were mentioned in the cartilage restoration market report. Major players have used collaboration, mergers, and acquisitions to increase their geographic presence and product range.
Маrkеt Кеу Рlауеrѕ:
- Zimmer Biomet
- Stryker Corp.
- DePuy Synthes
- Smith & Nephew PLC
- Vericel Corp.
- Osiris Therapeutics Inc.
- Braun Melsungen AG
- Arthrex Inc.
- Other Key Players
For the Cartilage Repair Market research study, the following years have been considered to estimate the market size:
Particular Scope Region - North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Historic Year 2016 to 2020 Estimated Year 2022 Forecast Year 2023 to 2032 Frequently Asked Questions (FAQ)
Q: What is the size of the Cartilage Repair market in 2021?
Q: What is the projected CAGR at which the Cartilage Repair market is expected to grow at?
Q: List the segments encompassed in this report on the Cartilage Repair market?
Q: List the key industry players of the Cartilage Repair market?
Q: Which region is more appealing for vendors employed in the Cartilage Repair market?
Q: Name the key areas of business for Cartilage Repair?
Q: Which segment accounts for the greatest market share in the Cartilage Repair industry?
- account_circleAbout Me
- ondemand_videoVideos
- Zimmer Biomet
- Stryker Corp.
- DePuy Synthes
- Smith & Nephew PLC
- Vericel Corp.
- Osiris Therapeutics Inc.
- B. Braun Melsungen AG Company Profile
- Arthrex Inc.
- Other Key Players
- settingsSettings
Our Clients
Request a Sample Report
We'll get back to you as quickly as possible
Single User
$5,999
$4,499
USD / per unit
save 25%
|
Multi User
$7,999
$4,999
USD / per unit
save 38%
|
Corporate User
$9,999
$5,499
USD / per unit
save 45%
|
|
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |